NIH-Funding

By: writedit

WriteEdit-Grant Questions Blog - Tue, 11/28/2017 - 17:54

With the federal budget in limbo, no one will know the FY18 appropriation for NIA … if nothing changes in the draft bills, paylines will be the same or better, since funding is slated to increase, but we need to see what Congress does in December and beyond.

Categories: NIH-Funding

By: Ruthie

WriteEdit-Grant Questions Blog - Tue, 11/28/2017 - 16:24

Thanks for the great information! I was wondering if you had any information on how NIA, specifically Alzheimer’s, will do with its FY18 appropriation?

Categories: NIH-Funding

By: writedit

WriteEdit-Grant Questions Blog - Tue, 11/28/2017 - 16:21

That is likely during the CR, since the entire NIH is operating on 90% of their FY17 budget, with final paylines to be set once the FY18 budget is set … which won’t be until next year. Currently, the NCI in particular should do well with its FY18 appropriation, but Congress may look at discretionary spending again to pay for tax cuts, if the current bill passes.

Categories: NIH-Funding

By: imager

WriteEdit-Grant Questions Blog - Tue, 11/28/2017 - 14:11

We got it from two sources now (one twitter and one through a colleague who talked with a PO) that NCI will drop from 10th percentile to 8th with no ESI bonus – any other confirmation of that anywhere…?!

Categories: NIH-Funding

NHLBI Announces Plan to Fund a Limited HCHS/SOL Visit 3 Exam

NIH Funding Announcements - Tue, 11/28/2017 - 13:35
Notice NOT-HL-17-163 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)

NIH Funding Announcements - Tue, 11/28/2017 - 13:32
Funding Opportunity PAS-18-188 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications to NIA's Small Business Technology Transfer Research (STTR)program to conduct research leading to the development of innovative products and/or services that may advance progress in preventing and treating Alzheimer's disease (AD) and Alzheimer's-disease-related dementias (ADRD) and/or caring for and treating AD/ADRD patients.
Categories: NIH-Funding

Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)

NIH Funding Announcements - Tue, 11/28/2017 - 13:30
Funding Opportunity PAS-18-187 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications to NIA's Small Business Innovation Research (SBIR) program to conduct research leading to the development of innovative products and/or services that may advance progress in preventing and treating Alzheimer's disease (AD) and Alzheimer's-disease-related dementias (ADRD) and/or caring for and treating AD/ADRD patients.
Categories: NIH-Funding

Products to Support Applied Research Towards Zero Suicide Healthcare Systems (R43/R44 Clinical Trial Optional)

NIH Funding Announcements - Tue, 11/28/2017 - 13:28
Funding Opportunity PAR-18-269 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) is intended to support Small Business Innovation Research (SBIR) grants that develop novel technologies for the purpose of advancing the National Action Alliance for Suicide Prevention's Zero Suicide goal of preventing suicide events (attempts, deaths) among individuals receiving treatment within health care systems. Zero Suicide is a commitment to the prevention of suicide among individuals served by health care systems and is also a specific set of health care strategies and tools intended to eliminate suicide events. Research is still needed, however, to implement these goals effectively, and the incorporation of health information technology (health IT) products into this care program is critical. As such, this FOA specifically supports SBIR grants to develop technologies that enable healthcare settings to improve the development, management and/or delivery of services under the Zero Suicide framework.
Categories: NIH-Funding

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)

NIH Funding Announcements - Tue, 11/28/2017 - 13:26
Funding Opportunity PAR-18-247 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for intervention research designed to support caregivers of adult cancer patients. Interventions supported by this FOA are intended to provide caregivers with care training, promote coping skills, and ultimately help them manage care. Outcomes of such interventions are expected to (1) optimize patient health care utilization, (2) improve caregiver well-being, and (3) improve patient physical health and psychosocial outcomes.
Categories: NIH-Funding

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)

NIH Funding Announcements - Tue, 11/28/2017 - 13:13
Funding Opportunity PAR-18-246 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for intervention research designed to support caregivers of adult cancer patients. Interventions supported by this FOA are intended to provide caregivers with care training, promote coping skills, and ultimately help them manage care. Outcomes of such interventions are expected to (1) optimize patient health care utilization, (2) improve caregiver well-being, and (3) improve patient physical health and psychosocial outcomes.
Categories: NIH-Funding

Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R43/R44 Clinical Trial Optional)

NIH Funding Announcements - Tue, 11/28/2017 - 12:38
Funding Opportunity PAR-18-186 from the NIH Guide for Grants and Contracts. The purpose of this Small Business Innovation Research (SBIR) FOA is to encourage small businesses to develop assistive robotics and related technology that would enhance health and reduce illness and disability in older Americans suffering from Alzheimer's Disease (AD), AD-related dementias (ADRD), and other comorbidities. In addition, this FOA encourages small businesses to develop assistive robotics addressing the needs and conditions of caregivers to older Americans suffering from AD and ADRD.
Categories: NIH-Funding

Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R41/R42 Clinical Trial Optional)

NIH Funding Announcements - Tue, 11/28/2017 - 12:25
Funding Opportunity PAR-18-185 from the NIH Guide for Grants and Contracts. The purpose of this Small Business Technology Transfer Research (STTR) FOA is to encourage small businesses and their research partners to develop assistive robotics and related technology that would enhance health and reduce illness and disability in older Americans suffering from Alzheimer's Disease (AD), AD-related dementias (ADRD), and other comorbidities. In addition, this FOA encourages small businesses and their research partners to develop assistive robotics addressing the needs and conditions of caregivers to older Americans suffering from AD and ADRD.
Categories: NIH-Funding

T2 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional)

NIH Funding Announcements - Tue, 11/28/2017 - 12:20
Funding Opportunity PAR-18-184 from the NIH Guide for Grants and Contracts. The involvement of small businesses in translational aging research could hasten the pace at which scientific advances are transformed into commercial products to improve or maintain the health and functional independence of older adults. Therefore, this funding opportunity announcement (FOA) is intended to support innovative research conducted by small businesses through the SBIR program to advance the availability of novel devices, products, health care practices and programs with the potential for commercial success and the likelihood to benefit the lives of older adults.
Categories: NIH-Funding

T1 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional)

NIH Funding Announcements - Tue, 11/28/2017 - 12:13
Funding Opportunity PAR-18-183 from the NIH Guide for Grants and Contracts. The involvement of small businesses in translational aging research could substantially hasten the pace at which scientific advances are transformed into commercial products to improve or maintain the health and functional independence of older adults. Therefore, this funding opportunity announcement (FOA) is intended to encourage a greater involvement by small businesses through the SBIR mechanism in transforming scientific advances in aging research into novel devices, products, health care practices and programs that will benefit the lives of older adults.
Categories: NIH-Funding

Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (R41/R42 Clinical Trial Optional)

NIH Funding Announcements - Tue, 11/28/2017 - 12:09
Funding Opportunity PAS-18-121 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that will develop and/or validate devices or electronic systems that can: 1) monitor biologically- or behaviorally-based processes applicable to mind and body interventions or 2) be used to assist in optimizing the practice or increasing the efficacy of mind and body interventions. The applications should: 1) lead to the development of new technologies, 2) adapt existing innovative technologies, devices and/or electronic systems, 3) repurpose existing devices and electronic systems, or 4) conduct testing of single or combined components of an integrated, long term, automated, wearable monitoring, stimulation device or electronic system in order to monitor or enhance the mechanistic processes or functional outcomes of mind and body interventions. For the purposes of this FOA, mind and body interventions are defined as non-pharmacological approaches that include mind/brain focused interventions (e.g., meditation, hypnosis), body-based approaches (e.g., acupuncture, massage, spinal manipulation/mobilization), or combined mind and body meditative movement approaches (e.g., yoga, tai-chi, qigong).
Categories: NIH-Funding

Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (R43/R44 Clinical Trial Optional)

NIH Funding Announcements - Tue, 11/28/2017 - 12:06
Funding Opportunity PAS-18-120 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that will develop and/or validate devices or electronic systems that can: 1) monitor biologically- or behaviorally-based processes applicable to mind and body interventions or 2) be used to assist in optimizing the practice or increasing the efficacy of mind and body interventions. The applications should: 1) lead to the development of new technologies, 2) adapt existing innovative technologies, devices and/or electronic systems, 3) repurpose existing devices and electronic systems, or 4) conduct testing of single or combined components of an integrated, long term, automated, wearable monitoring, stimulation device or electronic system in order to monitor or enhance the mechanistic processes or functional outcomes of mind and body interventions. For the purposes of this FOA, mind and body interventions are defined as non-pharmacological approaches that include mind/brain focused interventions (e.g., meditation, hypnosis), body-based approaches (e.g., acupuncture, massage, spinal manipulation/mobilization), or combined mind and body meditative movement approaches (e.g., yoga, tai-chi, qigong).
Categories: NIH-Funding

Evaluating the NIDA Standardized Research E-Cigarette in Risk Reduction and Related Studies (U01 Clinical Trial Optional)

NIH Funding Announcements - Tue, 11/28/2017 - 12:03
Funding Opportunity PAR-18-220 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to accelerate research evaluating electronic cigarettes (e-cigarettes, electronic nicotine delivery systems, ENDS) as a potential means of reducing the risks associated with combustible tobacco use. This goal will be achieved by funding clinical studies that use the newly-developed NIDA Standard Research E-cigarette (SREC) to examine potential risks and benefits associated with e-cigarette use in current tobacco smokers. Ultimately, this FOA aims to evaluate whether e-cigarettes can reduce the risks associated with combustible tobacco use and to establish the NIDA SREC as a standard to which other e-cigarettes can be compared. Studies submitted to this FOA should examine the effects of the SREC on multiple behavioral and health biomarkers in current tobacco smokers and may include examination of whether e-cigarettes can reduce the negative health impacts of conventional tobacco use, and / or examine their effects on craving and dependence. Funding will be contingent upon the FDA Center for Tobacco Products (CTP) determination that the studies fall under their regulatory jurisdiction. Furthermore, funding will require that CTP accepts the use of the NIDA SREC as an Investigational Tobacco Product (ITP) in the proposed study, or determines that an ITP is not required. Studies funded by this FOA are expected to rapidly increase understanding of whether e-cigarettes reduce the risks associated with tobacco use. Additionally, these studies may provide significant data to inform e-cigarette public health policy decision-making.
Categories: NIH-Funding

Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01 Clinical Trial Optional)

NIH Funding Announcements - Tue, 11/28/2017 - 12:00
Funding Opportunity PAR-18-215 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in women during pregnancy and lactation. The overall goals of the FOA are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations.
Categories: NIH-Funding

Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional)

NIH Funding Announcements - Tue, 11/28/2017 - 11:58
Funding Opportunity PAR-18-214 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in women during pregnancy and lactation. The overall goals of the FOA are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations.
Categories: NIH-Funding